Effects of Bisphosphonates on OI-Related Hearing Loss
NCT04152551
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Osteogenesis Imperfecta
Interventions
DRUG:
Risedronate Oral Tablet
Sponsor
Hospital for Special Surgery, New York
Collaborators
[object Object]
[object Object]
[object Object]